colestipol has been researched along with oligonucleotides in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Berger, J; Bookout, AL; Forss-Petter, S; Kunze, M; Rampler, H; Weinhofer, I | 1 |
Cai, T; Can, A; Castro, VM; Dligach, D; Du, R; Finan, S; Gainer, V; Murphy, S; Savova, G; Shadick, NA; Weiss, ST; Yu, S | 1 |
2 other study(ies) available for colestipol and oligonucleotides
Article | Year |
---|---|
Liver X receptor alpha interferes with SREBP1c-mediated Abcd2 expression. Novel cross-talk in gene regulation.
Topics: Adenosine Triphosphate; Adipose Tissue; Amino Acid Motifs; Animals; ATP Binding Cassette Transporter, Subfamily D; ATP-Binding Cassette Transporters; Binding Sites; Blotting, Northern; Blotting, Western; Cell Line, Tumor; Cells, Cultured; Chlorocebus aethiops; Cholesterol; Colestipol; COS Cells; Dimerization; DNA-Binding Proteins; Down-Regulation; Gene Expression Regulation; Humans; Ligands; Liver; Liver X Receptors; Lovastatin; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Models, Genetic; Monocytes; Mutagenesis; Oligonucleotides; Orphan Nuclear Receptors; Plasmids; Point Mutation; PPAR alpha; Promoter Regions, Genetic; Protein Binding; Protein Structure, Tertiary; Receptors, Cytoplasmic and Nuclear; Reverse Transcriptase Polymerase Chain Reaction; RNA; Sterol Regulatory Element Binding Protein 1; Sterols; Time Factors; Transcription, Genetic; Transfection | 2005 |
Lipid-Lowering Agents and High HDL (High-Density Lipoprotein) Are Inversely Associated With Intracranial Aneurysm Rupture.
Topics: Adult; Aged; Aneurysm, Ruptured; Benzimidazoles; Cholesterol, HDL; Cholesterol, LDL; Cholestyramine Resin; Colestipol; Ezetimibe; Female; Fibric Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Intracranial Aneurysm; Logistic Models; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Oligonucleotides; PCSK9 Inhibitors; Propensity Score; Protective Factors | 2018 |